![]() |
|
|
Vol. 62, Issue 6, 1344-1355, December 2002
Center for Development of Experimental Models in Medicine and
Biology (H.A.B), Interdisciplinary Center for Biochemical Research
(R.C.A.), and Departments of Biophysics (A.C.M.P., J.B.P.) and
Pharmacology (M.C.W.A.), Universidade Federal de São Paulo,
São Paulo, Brazil; Universidade Mogi das Cruzes, Mogi das Cruzes,
Brazil; Department of Physiology and Biophysics, Universidade Federal
de Minas Gerais, Belo Horizonte, Brazil (J.L.P.); Institut Louis
Bugnard, Institut National de la Santé et de la Recherche
Médicale U388 (J.P.S., J.L.B.) and U531 (J.P.E.), Toulouse,
France; and Max-Delbrück Center for Molecular Medicine,
Berlin-Buch, Germany (M.B.)
Kinins are involved in a variety of physiological and
pathophysiological processes related to cardiovascular homeostasis, inflammation, blood flow, and nociception. Under physiological conditions, the bradykinin B2 (BKB2) receptor is constitutively expressed and mediates most of kinins' actions. However, the
mechanisms regulating BKB2 receptor gene expression are still poorly
understood. In this study, 4.6 kilobases of the 5'-flanking
region from the rat BKB2 receptor gene were sequenced, and computer
analysis revealed several sites for transcriptional factors. Nine
promoter mutants were cloned in luciferase reporter gene vectors and
transfected in NG108-15 cells and rat aorta vascular smooth muscle
cells (VSMCs), showing several positive and negative regulatory
elements. A classical silencer with 56 base pairs (bp) caused a
decrease in reporter gene activity in NG108-15 cells and VSMCs and was
able to inhibit the thymidine kinase promoter. Using electrophoretic
mobility shift assay and surface plasmon resonance assay, protein-DNA
interactions in the silencer region were determined and specific sets
of protein-silencer complexes were detected in both cell types. More
intense complexes were observed in the central 21 bp of the silencer
and mutation in a putative SRE-1 site strongly impaired the protein-DNA
binding. Down-regulation of the BKB2 receptor population in NG108-15
cells promoted by N6,
2'-O-dibutyryladenosine 3':5'-cyclic monophosphate was
paralleled by an increase in the amount of nuclear proteins bound to
the silencer sequence showing an inverse relationship between
protein-silencer complexes and the transcription of the BKB2 receptor
gene. In summary, these data highlight the cell-specific regulation of the BKB2 receptor and the importance of a silencer element present in
the regulatory region of the gene.
This article has been cited by other articles:
![]() |
B. Shen, L. M. Harrison-Bernard, A. J. Fuller, V. Vanderpool, Z. Saifudeen, and S. S. El-Dahr The Bradykinin B2 Receptor Gene Is a Target of Angiotensin II Type 1 Receptor Signaling J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1140 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Trujillo, M. Sakagashira, and N. L. Eberhardt The Human Growth Hormone Gene Contains a Silencer Embedded within an Alu Repeat in the 3'-Flanking Region Mol. Endocrinol., October 1, 2006; 20(10): 2559 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zamorano, S. Suchindran, and J. V. Gainer 3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression Am J Physiol Renal Physiol, February 1, 2006; 290(2): F456 - F464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. B. Martins, R. R. Resende, P. Majumder, M. Faria, D. E. Casarini, A. Tarnok, W. Colli, J. B. Pesquero, and H. Ulrich Neuronal Differentiation of P19 Embryonal Carcinoma Cells Modulates Kinin B2 Receptor Gene Expression and Function J. Biol. Chem., May 20, 2005; 280(20): 19576 - 19586. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF] |
||||